Shanghai, China

Qingfeng Li

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Qingfeng Li

Introduction

Qingfeng Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals and biotechnology. With a total of five patents to his name, his work focuses on innovative methods and compositions that target drug delivery and cellular processes.

Latest Patents

Qingfeng Li's latest patents include a composition of drug targets and a method of using them. This composition comprises a vector and a drug utilizing FKBP10 and PCOLCE genes and/or the encoded proteins as drug targets. Another notable patent involves pharmaceutical compositions and methods for activating human fibroblast and myofibroblast apoptosis. This invention provides a method for activating apoptosis in mammalian tissues by administering a therapeutically effective amount of a composition containing specific siRNA molecules and a pharmaceutically acceptable carrier.

Career Highlights

Throughout his career, Qingfeng Li has worked with notable organizations such as Shanghai United Imaging Intelligence Co., Ltd. and Shanghai Jiaotong University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative medical solutions.

Collaborations

Qingfeng Li has collaborated with several professionals in his field, including Quan Huo and Feng Shi. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Qingfeng Li's contributions to the field of pharmaceuticals and biotechnology are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…